Jiayi Zhang

Jiayi Zhang is currently a Senior Director of CMC at WuXi Biologics, overseeing multiple programs from early to late phases. Previously, Jiayi served as Technical Director at GSK, where responsibilities included making critical CMC technical decisions for accelerated programs such as the GSK Covid-19 antibody Sotrovimab and the oncology product Jemperli. At Sanofi Genzyme, Jiayi held various roles, culminating as Technical Director, where a focus was placed on ensuring product quality throughout the supply chain for a portfolio of rare blood disease products. Prior experience includes serving as an upstream lab head and process engineer at Sanofi, as well as a research scientist at Mascoma Corp, leading process development for a large-scale fermentation process. Jiayi holds a BE/MS in Chemical Engineering from Zhejiang University and a Ph.D. in Chemical and Biochemical Engineering from Dartmouth College.